CPIM
ONCE

Columbia Partners Investment Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Columbia Partners Investment Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,074
Closed -$822K – 166
2018
Q3 		$822K Hold
15,074
– – 0.21% 130
2018
Q2 		$1.25M Sell
15,074
-5,900
-28% -$455K 0.36% 97
2018
Q1 		$1.4M Buy
+20,974
New +$1.21M 0.18% 157

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Columbia Partners Investment Management's ONCE Position: Q4 2018 in Review

Columbia Partners Investment Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 15,074 shares — an estimated $822K sold.

Columbia Partners Investment Management first reported a position in ONCE in Q1 2018 and held it in 3 quarters. The position peaked at $1.4M in Q1 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

  • Columbia Partners Investment Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 15,074 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $822K.
  • Columbia Partners Investment Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • Columbia Partners Investment Management's Spark Therapeutics, Inc. Common Stock position peaked at $1.4M in Q1 2018.
  • 157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.